HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Boceprevir
Description
Boceprevir is a direct acting protease inhibitor for the treatment of hepatitis C. It also has two isomers in which the S isomer is more active than the R-isomer. FDA approved on May 13, 2011.
No brand information found.
